Cargando…

2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach

BACKGROUND: Community parenteral antimicrobial therapy (CoPAT) allows patients to receive intravenous (IV) antimicrobials outside the hospital; however, inappropriate use occurs and can lead to adverse outcomes. In addition, these patients are at high risk of readmission. Our objective was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckel, Whitney R, Olson, Jared, Hersh, Adam, Matheu, Michelle, Stenehjem, Edward A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808935/
http://dx.doi.org/10.1093/ofid/ofz360.1739
_version_ 1783461858795061248
author Buckel, Whitney R
Olson, Jared
Hersh, Adam
Matheu, Michelle
Stenehjem, Edward A
author_facet Buckel, Whitney R
Olson, Jared
Hersh, Adam
Matheu, Michelle
Stenehjem, Edward A
author_sort Buckel, Whitney R
collection PubMed
description BACKGROUND: Community parenteral antimicrobial therapy (CoPAT) allows patients to receive intravenous (IV) antimicrobials outside the hospital; however, inappropriate use occurs and can lead to adverse outcomes. In addition, these patients are at high risk of readmission. Our objective was to assess the quality of CoPAT in a large healthcare system in order to guide implementation of an intervention requiring mandatory review by antimicrobial stewardship. METHODS: We identified patients with orders for IV antimicrobials at discharge between January 1 and December 10, 2018. Patients were excluded if transferred to an acute care facility, left against medical advice, or died. 250 patients were selected using a random number generator and reviewed consecutively until 100 confirmed CoPAT encounters were identified. Each encounter was evaluated for evidence of ID consultation, opportunities for stewardship interventions in seven categories (See Table 1), and adverse events such as emergency room (ER) visits and readmissions. RESULTS: The query identified 4,642 potential CoPAT discharges from 22 hospitals (see Table 2). 117 encounters were reviewed to reach 100 true CoPAT discharges (85% query accuracy). Of these, 55 (55%) received a formal ID consult, 6 (6%) had an ID pharmacist or ID physician curbside, and 5 (5%) had an ID clinic follow-up appointment scheduled without formal ID consult. Opportunity for stewardship intervention was found in 50 (50%) patients (see Table 1). There were 31 (31%) patients who were seen in the ER (n = 21) and/or re-admitted (n = 19) to the hospital during or shortly after completion of CoPAT, of which 25 (81%) were potentially related to CoPAT, including abnormal laboratory findings, PICC-line complications, and signs or symptoms of infection. CONCLUSION: CoPAT patients are complex with high healthcare utilization. Mandatory ID review of patients receiving CoPAT has the potential to impact 2,000 lives annually in a large health system. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6808935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68089352019-10-28 2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach Buckel, Whitney R Olson, Jared Hersh, Adam Matheu, Michelle Stenehjem, Edward A Open Forum Infect Dis Abstracts BACKGROUND: Community parenteral antimicrobial therapy (CoPAT) allows patients to receive intravenous (IV) antimicrobials outside the hospital; however, inappropriate use occurs and can lead to adverse outcomes. In addition, these patients are at high risk of readmission. Our objective was to assess the quality of CoPAT in a large healthcare system in order to guide implementation of an intervention requiring mandatory review by antimicrobial stewardship. METHODS: We identified patients with orders for IV antimicrobials at discharge between January 1 and December 10, 2018. Patients were excluded if transferred to an acute care facility, left against medical advice, or died. 250 patients were selected using a random number generator and reviewed consecutively until 100 confirmed CoPAT encounters were identified. Each encounter was evaluated for evidence of ID consultation, opportunities for stewardship interventions in seven categories (See Table 1), and adverse events such as emergency room (ER) visits and readmissions. RESULTS: The query identified 4,642 potential CoPAT discharges from 22 hospitals (see Table 2). 117 encounters were reviewed to reach 100 true CoPAT discharges (85% query accuracy). Of these, 55 (55%) received a formal ID consult, 6 (6%) had an ID pharmacist or ID physician curbside, and 5 (5%) had an ID clinic follow-up appointment scheduled without formal ID consult. Opportunity for stewardship intervention was found in 50 (50%) patients (see Table 1). There were 31 (31%) patients who were seen in the ER (n = 21) and/or re-admitted (n = 19) to the hospital during or shortly after completion of CoPAT, of which 25 (81%) were potentially related to CoPAT, including abnormal laboratory findings, PICC-line complications, and signs or symptoms of infection. CONCLUSION: CoPAT patients are complex with high healthcare utilization. Mandatory ID review of patients receiving CoPAT has the potential to impact 2,000 lives annually in a large health system. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808935/ http://dx.doi.org/10.1093/ofid/ofz360.1739 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Buckel, Whitney R
Olson, Jared
Hersh, Adam
Matheu, Michelle
Stenehjem, Edward A
2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
title 2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
title_full 2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
title_fullStr 2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
title_full_unstemmed 2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
title_short 2059. Antimicrobial Stewardship of Community Parenteral Antimicrobial Therapy: A Health System Approach
title_sort 2059. antimicrobial stewardship of community parenteral antimicrobial therapy: a health system approach
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808935/
http://dx.doi.org/10.1093/ofid/ofz360.1739
work_keys_str_mv AT buckelwhitneyr 2059antimicrobialstewardshipofcommunityparenteralantimicrobialtherapyahealthsystemapproach
AT olsonjared 2059antimicrobialstewardshipofcommunityparenteralantimicrobialtherapyahealthsystemapproach
AT hershadam 2059antimicrobialstewardshipofcommunityparenteralantimicrobialtherapyahealthsystemapproach
AT matheumichelle 2059antimicrobialstewardshipofcommunityparenteralantimicrobialtherapyahealthsystemapproach
AT stenehjemedwarda 2059antimicrobialstewardshipofcommunityparenteralantimicrobialtherapyahealthsystemapproach